Upadacitinib Tartrate | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Upadacitinib Tartrate
FDA Orange Book

PharmaCompass Sponsored Ads

Contact Supplier

Upadacitinib

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Upadacitinib Tartrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 10 USDMF, 1 KDMF, 6 NDC API, 28 Listed Suppliers, $ API Reference Price

35 API Suppliers
10 USDMF
1 KDMF
6 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

67 Drugs in Development

67 Drugs in Development

INTERMEDIATES

40 Intermediate Suppliers

40 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 6 FDA Orange Book, 1 Europe, 3 Canada, 24 Australia, 1 South Africa

35 FDF Dossiers
6 FDA Orange Book
1 Europe
3 Canada
24 Australia
1 South Africa

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 136 News #PharmaBuzz

3 Data Compilation #PharmaFlow
136 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
1 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

5 APIs, 2 FDF Dossiers

5 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

100 US Patents, 20 US Exclusivities

100 US Patents
20 US Exclusivities

$ API Ref.Price (USD/KG) : 77,355 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 4ABBVIE

02 2AUROBINDO PHARMA LTD

filter Dosage Reset all filters

6 All

01 1SOLUTION;ORAL

02 3TABLET, EXTENDED RELEASE;ORAL

03 2TABLET;ORAL

filter Regulatory Info Reset all filters

6 All

01 4RX

02 2Blank

filter Brand Name Reset all filters

6 All

01 3RINVOQ

02 1RINVOQ LQ

03 2UPADACITINIB

filter RLD Reset all filters

6 All

01 4Yes

02 2Blank

Zhejiang Hengkang

List of Suppliers

Product Main Page

01

ABBVIE

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

RLD : Yes

TE Code :

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 15MG

Approval Date : 2019-08-16

Application Number : 211675

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

RLD : Yes

TE Code :

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 30MG

Approval Date : 2022-01-14

Application Number : 211675

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ABBVIE

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

RLD : Yes

TE Code :

UPADACITINIB

Brand Name : RINVOQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 45MG

Approval Date : 2022-03-16

Application Number : 211675

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ABBVIE

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

RLD : Yes

TE Code :

UPADACITINIB

Brand Name : RINVOQ LQ

Dosage Form : SOLUTION;ORAL

Dosage Strength : 1MG/ML

Approval Date : 2024-04-26

Application Number : 218347

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

AUROBINDO PHARMA LTD

IMCAS Asia

Not Confirmed

AUROBINDO PHARMA LTD

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

UPADACITINIB

Brand Name : UPADACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 15MG

Approval Date :

Application Number : 218866

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

06

AUROBINDO PHARMA LTD

IMCAS Asia

Not Confirmed

AUROBINDO PHARMA LTD

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

UPADACITINIB

Brand Name : UPADACITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Approval Date :

Application Number : 218866

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!